Dyadic International's Upcoming Industry Engagements
Dyadic International, Inc. (NASDAQ: DYAI) is gearing up for a series of noteworthy industry events in the coming months, aiming to amplify its presence in the biotechnology sector. The company's focus lies in the efficient large-scale production of proteins that play a crucial role in human and animal vaccines, therapeutics, and a variety of non-pharmaceutical applications that include food and industrial uses.
Highlighted Events
World AGRI-Tech Innovation Summit
Set to take place from March 11-12, 2025, this summit gathers global innovators in agriculture technology. Dyadic will be present to showcase its advanced protein manufacturing capabilities, which are vital for next-generation agricultural practices and food security solutions.
Future Food-Tech Conference
On March 13-14, 2025, Dyadic will participate in the Future Food-Tech Conference in San Francisco, California. At this event, Dyadic will highlight its cutting-edge technologies at Booth No: #2. The conference aims to foster collaborations that will pave the way for sustainable food production methods.
Microbial Engineering III
From March 30 to April 3, 2025, Dyadic will attend the Microbial Engineering III event in Porto, Portugal. This conference focuses on the latest advancements in microbial technologies essential for the development of innovative protein production processes. The insights shared at this gathering will underscore Dyadic's commitment to advancing biotechnology.
Contact for Meetings
If you're interested in learning more about Dyadic International or wish to schedule a meeting with its management during these events, please reach out via email at contact@dyadic.com.
About Dyadic International, Inc.
Dyadic International, Inc. is dedicated to revolutionizing the biotechnology field with its innovative approaches to protein manufacturing. The company harnesses advanced microbial gene expression platforms, particularly the productive and scalable fungus Thermothelomyces heterothallica. This technology supports not only vaccine and therapeutic production but also enhances outputs in food, nutrition, and wellness sectors.
The C1-cell protein production platform, a cornerstone of Dyadic's operations, is an industrially proven method that allows for cost-effective and efficient manufacturing of biologic products. Furthermore, the newly developed Dapibus™ platform is tailored for large-scale production of proteins and metabolites that cater to various non-pharmaceutical markets.
The Future Ahead for Dyadic
Dyadic is strategically positioned to leverage its innovative microbial technologies. The company is eyeing a broad scope of applications that extend across human and animal health, food, and wellness. Their ongoing collaborations and research projects aim to unlock new potential in the biotechnology landscape, ensuring they remain at the forefront of industry developments.
Frequently Asked Questions
What is Dyadic International focused on?
Dyadic International is focused on the efficient production of proteins for vaccines, therapeutics, and various non-pharmaceutical applications.
When are the upcoming events Dyadic will attend?
Dyadic will participate in several key industry events from March to April 2025, including the World AGRI-Tech Innovation Summit and Future Food-Tech Conference.
How can I meet with Dyadic management?
Interested parties should contact Dyadic via email at contact@dyadic.com to schedule meetings during the events.
What technology does Dyadic use for protein production?
Dyadic utilizes advanced microbial gene expression platforms based on the fungus Thermothelomyces heterothallica for scalable protein production.
Where can I learn more about Dyadic International?
For more information regarding Dyadic International, you can visit their website at www.dyadic.com.
